Vaccine and Treatment Evaluation Units: Phase I Clinical Trial to Evaluate a Zika Vaccine Candidate

NIH RePORTER · NIH · N01 · $726,955 · view on reporter.nih.gov ↗

Abstract

This program is comprised of a consortium of individual contracts within academic centers and organizations that provide a ready resource for the design and conduct of clinical trials to evaluate promising products to combat infectious diseases.

Key facts

NIH application ID: 10683482
Project number: 272201300021I-P00003-27200021-1
Recipient: SAINT LOUIS UNIVERSITY
Principal Investigator: SARAH GEORGE
Activity code: N01
Funding institute: NIH
Fiscal year: 2022
Award amount: $726,955
Award type: —
Project period: 2017-09-15 → 2023-07-31